Form 8-K - Current report:
SEC Accession No. 0001193125-14-045594
Filing Date
2014-02-11
Accepted
2014-02-11 16:22:08
Documents
17
Period of Report
2014-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d674309d8k.htm 8-K 49889
2 EX-2.1 d674309dex21.htm EX-2.1 413968
3 EX-99.1 d674309dex991.htm EX-99.1 82570
4 EX-99.2 d674309dex992.htm EX-99.2 28533
5 EX-99.3 d674309dex993.htm EX-99.3 35360
6 GRAPHIC g6743091.jpg GRAPHIC 101753
7 GRAPHIC g67430910.jpg GRAPHIC 231434
8 GRAPHIC g67430911.jpg GRAPHIC 226673
9 GRAPHIC g67430912.jpg GRAPHIC 239320
10 GRAPHIC g6743092.jpg GRAPHIC 345600
11 GRAPHIC g6743093.jpg GRAPHIC 307994
12 GRAPHIC g6743094.jpg GRAPHIC 290518
13 GRAPHIC g6743095.jpg GRAPHIC 224232
14 GRAPHIC g6743096.jpg GRAPHIC 273939
15 GRAPHIC g6743097.jpg GRAPHIC 264181
16 GRAPHIC g6743098.jpg GRAPHIC 181881
17 GRAPHIC g6743099.jpg GRAPHIC 200610
  Complete submission text file 0001193125-14-045594.txt   4592388
Mailing Address DAMASTOWN INDUSTRIAL ESTATE MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN INDUSTRIAL ESTATE MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 14594561
SIC: 2834 Pharmaceutical Preparations